Revenue

Health Union's new platform for ATTR amyloidosis isn't just a website. It's a strategic blend of patient support and business innovation. Here's why.

With a $2.5B boost from Blue Owl, Finance of America aims to move beyond reverse mortgages and reshape how millions of retirees access their home equity.

AMC's key governance reforms failed despite 90% voter support, stymied by low turnout. Meanwhile, a major share increase passed. What does this mean?

Serina Therapeutics poaches a top chemist to expand its POZ platform, signaling a major push beyond Parkinson's into new, high-value drug markets.

Brixton Metals secures nearly $10M in a complex financing deal. Here’s why this capital is a game-changer for its flagship Thorn copper-gold project.

Financial Institutions, Inc. executes a savvy debt refinancing, cutting costs by over $1M annually and fortifying its balance sheet for future growth.

As John Lindsay retires, H&P anoints tech-savvy insider Trey Adams. A look at how this smooth transition secures a legacy of innovation.

Erie Indemnity boosts its dividend by 7.1%, but a deeper look reveals a unique and legally challenged fee structure driving its profitability.

Compass predicts a balanced 2026 housing market, but a deeper look reveals a split: modest relief for many and a luxury boom fueled by AI-driven wealth.

Datavault AI is issuing a 'meme coin' to shareholders. Is this the future of corporate rewards or a regulatory tightrope walk with a speculative asset?

A new partnership between KBRA Analytics and Intex Solutions streamlines CMBS analysis, promising to enhance risk management in volatile economic times.

Zoetis boosts its dividend by 6%, but what does this move signal about the company's financial health and the booming global animal care market?

Tenaya Therapeutics unveils promising interim data for its ARVC gene therapy, TN-401, hinting at a potential cure and igniting investor interest.

BrightView Holdings declared its eighth straight cash dividend, a move signaling financial discipline even as it navigates revenue challenges and stock volatility.

Tenaya Therapeutics seeks fresh capital to advance its heart disease pipeline, but the offering's structure raises dilution questions for investors.

Dynex's routine dividend declaration reveals a complex strategy of risk management and capital allocation, offering a masterclass in navigating mREIT turbulence.

Excelerate Energy signals deep confidence with a new $75M share buyback, balancing shareholder rewards with an ambitious global expansion in the LNG market.

PG&E's new grid tech does more than keep lights on; it's a vital upgrade for healthcare resilience, wildfire prevention, and safety in a changing climate.

AutoNation's latest acquisition in Baltimore is more than just a line item. It's a strategic move in the high-stakes game of auto retail consolidation.

A routine filing reveals a major strategic play. See how BridgeBio Oncology uses special equity grants to attract top minds in the fierce race for a cancer cure.